Biologics & Bioprocessing
Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
January 2016 onwards
Submit An Event
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
05 Nov 2012 - 06 Nov 2012
Cell Culture & Bioprocessing Congress
05 Nov 2012 - 07 Nov 2012
Biologics World China 2012
07 Nov 2012 - 08 Nov 2012
Philadelphia, PA USA
Automation Fair 2012
12 Nov 2012 - 13 Nov 2012
Washington, DC, USA
Cell Culture World Congress USA
12 Nov 2012 - 12 Nov 2012
Biologics World Taiwan 2012
12 Nov 2012 - 14 Nov 2012
Johannes Gutenberg-University, Mainz, Germany
Introductory GastroPlus™ Simulation & Modeling Workshop for Drug Absorption, Pharmacokinetics and Pharmacodynamics
14 Nov 2012 - 14 Nov 2012
Stevenage, Hertfordshire, UK
3rd Annual Miniaturisation Event - Micro Scale Bioprocess Development
15 Nov 2012 - 16 Nov 2012
8th Annual Project & Portfolio Management in Pharmaceutical Industry
23 Nov 2012 - 23 Nov 2012
Introduction to Photostability
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!